Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Failed Pediatric Study Data To Get FDA Review At Patient Meeting

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency officials plan discussion of how analysis of failed pediatric clinical trial data can improve future trials during annual patient network meeting.

Advertisement

Related Content

J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group
“Patient Voice” Report Puts Chronic Fatigue Symptoms, Treatments In Benefit/Risk Framework
FDA To Be More Vigilant About Proposed Clinical Trial Exclusions

Topics

Advertisement
UsernamePublicRestriction

Register

PS077443

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel